In an established tumor model, Hu-mice with similar CD8+ T-cell levels (Schema, Fig. 2f), treatment with anti-PD-1 antibody significantly restricted tumor growth of 2 different metastatic melanomas (WM3629 [HLA-A3]; Fig. 2g and A375 [HLA-A2]; Fig. 2h) when compared to tumor growth in Hu-mice treated with control IgG or non-reconstituted NSG mice treated with an anti-PD-1 antibody. The gene discussed is CD8A; the disease is neoplasm.